文献速递流行病学与生物统计临床试验与 GCP

复杂创伤后应激障碍及共病心理干预与药物干预的系统综述与成分网络Meta分析

Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
PubMed 文献 · PLoS Med · 2020-08-19

该系统综述与成分网络Meta分析纳入116项研究,评估心理与药物干预对复杂创伤暴露者PTSD及共病的效果。心理干预在减轻PTSD、抑郁、焦虑症状和改善睡眠质量上优于非活动对照,多成分干预(含认知重构与想象暴露)效果最佳。

要点

  • 心理干预可有效减轻复杂创伤后PTSD、抑郁和焦虑症状,并改善睡眠质量。
  • 多成分心理干预(含认知重构和想象暴露)对减少PTSD症状最有效。
  • 聚焦创伤的心理干预优于非聚焦创伤干预,但在退伍军人和战争受影响人群中效果减弱。

核心结论

  • 聚焦创伤的心理干预对复杂创伤暴露者的PTSD及共病有效。
  • 多成分干预(可包括分阶段方法)是管理复杂创伤PTSD最有效的治疗组合。

研究设计与样本

  • 系统综述与成分网络Meta分析,检索截至2019年10月25日的随机对照试验和非随机对照试验。
  • 参与者为经历复杂创伤的成人,平均年龄42.6±9.3岁,42%为男性。

主要发现

  • 心理干预在治疗后减少PTSD症状优于非活动对照(k=46;n=3389;SMD=-0.82,95%CI -1.02至-0.63)和活动对照(k=9;n=662;SMD=-0.35,95%CI -0.56至-0.14)。
  • 心理干预在6个月随访时仍优于非活动对照减少PTSD症状(k=10;n=738;SMD=-0.45,95%CI -0.82至-0.08)。
  • 心理干预减少抑郁症状(k=31;n=2075;SMD=-0.87,95%CI -1.11至-0.63)和焦虑症状(k=15;n=1395;SMD=-1.03,95%CI -1.44至-0.61)。
  • 抗精神病药物(k=5;n=364;SMD=-0.45;95%CI -0.85至-0.05)和哌唑嗪(k=3;n=110;SMD=-0.52;95%CI -1.03至-0.02)可有效减少PTSD症状。
  • 成分网络Meta分析显示,包含认知重构和想象暴露的多成分干预对减少PTSD症状最有效(k=17;n=1077;均差=-37.95,95%CI -60.84至-15.16)。

临床怎么用

  • 对复杂创伤暴露者,优先采用聚焦创伤的多成分心理干预(含认知重构和想象暴露)。
  • 心理干预可改善PTSD、抑郁、焦虑症状和睡眠质量,且脱落率较低。
  • 在退伍军人和战争受影响人群中,需注意心理干预效果可能减弱。

局限性

  • 采用非诊断性纳入策略可能遗漏某些患有严重持久精神共病的复杂创伤人群。
  • 基于技能干预成分的相对贡献无法在网状Meta分析中评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complex traumatic events associated with armed conflict, forcible displacement, childhood sexual abuse, and domestic violence are increasingly prevalent. People exposed to complex traumatic events are at risk of not only posttraumatic stress disorder (PTSD) but also other mental health comorbidities. Whereas evidence-based psychological and pharmacological treatments are effective for single-event PTSD, it is not known if people who have experienced complex traumatic events can benefit and tolerate these commonly available treatments. Furthermore, it is not known which components of psychological interventions are most effective for managing PTSD in this population. We performed a systematic review and component network meta-analysis to assess the effectiveness of psychological and pharmacological interventions for managing mental health problems in people exposed to complex traumatic events. METHODS AND FINDINGS: We searched CINAHL, Cochrane Central Register of Controlled Trials, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Published International Literature on Traumatic Stress, PsycINFO, and Science Citation Index for randomised controlled trials (RCTs) and non-RCTs of psychological and pharmacological treatments for PTSD symptoms in people exposed to complex traumatic events, published up to 25 October 2019. We adopted a nondiagnostic approach and included studies of adults who have experienced complex trauma. Complex-trauma subgroups included veterans; childhood sexual abuse; war-affected; refugees; and domestic violence. The primary outcome was reduction in PTSD symptoms. Secondary outcomes were depressive and anxiety symptoms, quality of life, sleep quality, and positive and negative affect. We included 116 studies, of which 50 were conducted in hospital settings, 24 were delivered in community settings, seven were delivered in military clinics for veterans or active military personnel, five were conducted in refugee camps, four used remote delivery via web-based or telephone platforms, four were conducted in specialist trauma clinics, two were delivered in home settings, and two were delivered in primary care clinics; clinical setting was not reported in 17 studies. Ninety-four RCTs, for a total of 6,158 participants, were included in meta-analyses across the primary and secondary outcomes; 18 RCTs for a total of 933 participants were included in the component network meta-analysis. The mean age of participants in the included RCTs was 42.6 ± 9.3 years, and 42% were male. Nine non-RCTs were included. The mean age of participants in the non-RCTs was 40.6 ± 9.4 years, and 47% were male. The average length of follow-up across all included studies at posttreatment for the primary outcome was 11.5 weeks. The pairwise meta-analysis showed that psychological interventions reduce PTSD symptoms more than inactive control (k = 46; n = 3,389; standardised mean difference [SMD] = -0.82, 95% confidence interval [CI] -1.02 to -0.63) and active control (k-9; n = 662; SMD = -0.35, 95% CI -0.56 to -0.14) at posttreatment and also compared with inactive control at 6-month follow-up (k = 10; n = 738; SMD = -0.45, 95% CI -0.82 to -0.08). Psychological interventions reduced depressive symptoms (k = 31; n = 2,075; SMD = -0.87, 95% CI -1.11 to -0.63; I2 = 82.7%, p = 0.000) and anxiety (k = 15; n = 1,395; SMD = -1.03, 95% CI -1.44 to -0.61; p = 0.000) at posttreatment compared with inactive control. Sleep quality was significantly improved at posttreatment by psychological interventions compared with inactive control (k = 3; n = 111; SMD = -1.00, 95% CI -1.49 to -0.51; p = 0.245). There were no significant differences between psychological interventions and inactive control group at posttreatment for quality of life (k = 6; n = 401; SMD = 0.33, 95% CI -0.01 to 0.66; p = 0.021). Antipsychotic medicine (k = 5; n = 364; SMD = -0.45; -0.85 to -0.05; p = 0.085) and prazosin (k = 3; n = 110; SMD = -0.52; -1.03 to -0.02; p = 0.182) were effective in reducing PTSD symptoms. Phase-based psychological interventions that included skills-based strategies along with trauma-focused strategies were the most promising interventions for emotional dysregulation and interpersonal problems. Compared with pharmacological interventions, we observed that psychological interventions were associated with greater reductions in PTSD and depression symptoms and improved sleep quality. Sensitivity analysis showed that psychological interventions were acceptable with lower dropout, even in studies rated at low risk of attrition bias. Trauma-focused psychological interventions were superior to non-trauma-focused interventions across trauma subgroups for PTSD symptoms, but effects among veterans and war-affected populations were significantly reduced. The network meta-analysis showed that multicomponent interventions that included cognitive restructuring and imaginal exposure were the most effective for reducing PTSD symptoms (k = 17; n = 1,077; mean difference = -37.95, 95% CI -60.84 to -15.16). Our use of a non-diagnostic inclusion strategy may have overlooked certain complex-trauma populations with severe and enduring mental health comorbidities. Additionally, the relative contribution of skills-based intervention components was not feasibly evaluated in the network meta-analysis. CONCLUSIONS: In this systematic review and meta-analysis, we observed that trauma-focused psychological interventions are effective for managing mental health problems and comorbidities in people exposed to complex trauma. Multicomponent interventions, which can include phase-based approaches, were the most effective treatment package for managing PTSD in complex trauma. Establishing optimal ways to deliver multicomponent psychological interventions for people exposed to complex traumatic events is a research and clinical priority.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Coventry PA, Meader N, Melton H, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. PLoS Med. 2020. PMID: 32813696. doi:10.1371/journal.pmed.1003262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。